TREVISAN ROBERTO

Ruolo:
Professore associato
Settore scientifico disciplinare:
Endocrinologia (MED/13)

Pubblicazioni

  • Trevisan, R., Conti, M., Ciardullo, S. (2024). Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes. DIABETOLOGIA [10.1007/s00125-024-06158-9]. Dettaglio

  • Mantovani, A., Morieri, M., Aldigeri, R., Palmisano, L., Masulli, M., Bonomo, K., et al. (2024). MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus. DIABETES & METABOLISM, 50(1 (January 2024)) [10.1016/j.diabet.2023.101497]. Dettaglio

  • Lepore, G., Borella, N., Castagna, G., Ippolito, S., Bonfadini, S., Corsi, A., et al. (2024). Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy. DIABETES TECHNOLOGY & THERAPEUTICS, 26(1 (January 5, 2024)), 49-58 [10.1089/dia.2023.0261]. Dettaglio

  • Ciardullo, S., Dodesini, A., Lepore, G., Corsi, A., Scaranna, C., Perseghin, G., et al. (2023). Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM [10.1210/clinem/dgad682]. Dettaglio

  • Orsi, E., Solini, A., Bonora, E., Vitale, M., Garofolo, M., Fondelli, C., et al. (2023). Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes. DIABETES & METABOLISM, 49(2 (March 2023)) [10.1016/j.diabet.2022.101413]. Dettaglio